Active Ingredient History

NOW
  • Now
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome, granulomatosis with polyangiitis, and following organ transplant, among other conditions. It is taken by mouth or injection into a vein.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral, Parenteral
  • Pro Drug: Yes

Drug Pricing (per unit)

Australia

$2.1949 - $37.0593

United States

$2.6757 - $941.7500
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

2-[bis(2-chloroethylamino)]-tetrahydro-2h-1,3,2-oxazaphosphorine-2-oxide | a-4828 | anhydrous cyclophosphamide | bis(2-chloroethyl)phosphoramide cyclic propanolamide ester | ciclofosfamida | ciclofosfamide | cyc | cyclophosphamid | cyclophosphamide | (+-)-cyclophosphamide | cyclophosphamide anhydrous | cyclophosphamide hydrate | cyclophosphamidum | cyclophosphan | cyclophosphane | cyclophosphomide | cycolophosphamide | cytophosphan | cytophosphane | cytoxan | cytoxan (lyophilized) | cytoxin | endoxan | endoxana | genoxal trofosfamida | gm-csf | horse thymoglobulin | ixoten | ledoxina | lyophilized cytoxan | mitoxan | neosar | n,n-3'-tris(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine, 2-oxide | n,n-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine 2-oxide | n,n,n'-tris(2-chloroethyl)-n'-o-propylene phosphoric acid ester diamide | panc 10.05 pcdna-1/gm-neo | panc 6.03 pcdna-1 neo | (rs)-cyclophosphamide | tetwtcea dna | trifosfamide | trilofosfamida | trilophosphamide | triphosphamide | trisfosfamide | trofosfamid | trofosfamide | trophosphamid | trophosphamide | z 4828 | z-4828

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue